Frank G. Holz mostly deals with Macular degeneration, Ophthalmology, Visual acuity, Fluorescein angiography and Pathology. His Macular degeneration research is multidisciplinary, incorporating perspectives in Retinal pigment epithelium, Lipofuscin, Retinopathy, Age related and Atrophy. His Ophthalmology research is multidisciplinary, incorporating elements of Retina and Ranibizumab.
His studies in Visual acuity integrate themes in fields like Diabetic retinopathy, Randomized controlled trial, Aflibercept and Clinical trial. Frank G. Holz focuses mostly in the field of Fluorescein angiography, narrowing it down to topics relating to Optical coherence tomography and, in certain cases, Outer nuclear layer. His Pathology research includes themes of Choroidal neovascularization, Angioid streaks and Macular disease.
The scientist’s investigation covers issues in Ophthalmology, Macular degeneration, Retinal, Visual acuity and Pathology. His work on Fluorescein angiography, Optical coherence tomography, Retinal pigment epithelium and Choroidal neovascularization as part of general Ophthalmology study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His biological study spans a wide range of topics, including Ophthalmoscopy and Angiography.
Frank G. Holz has included themes like Prospective cohort study, Age related and Atrophy in his Macular degeneration study. His Retinal study combines topics from a wide range of disciplines, such as Retinopathy, Retina and Autofluorescence. His work carried out in the field of Visual acuity brings together such families of science as Diabetic retinopathy, Optometry and Ranibizumab.
Frank G. Holz mainly focuses on Ophthalmology, Macular degeneration, Retinal, Visual acuity and Age related. Prospective cohort study is closely connected to Aflibercept in his research, which is encompassed under the umbrella topic of Ophthalmology. His Macular degeneration study combines topics in areas such as Retinal pigment epithelium, Clinical trial and Atrophy.
His Retinal research incorporates themes from Retina and Autofluorescence. His study looks at the relationship between Visual acuity and fields such as Adverse effect, as well as how they intersect with chemical problems. He combines subjects such as Multimodal imaging and MEDLINE with his study of Age related.
His primary areas of investigation include Ophthalmology, Macular degeneration, Visual acuity, Retinal and Optical coherence tomography. His study in Mesopic vision, Retinal pigment epithelium, Fundus, Microperimetry and Choroidal neovascularization is done as part of Ophthalmology. The study incorporates disciplines such as Choroid, Prospective cohort study, Age related and Atrophy in addition to Macular degeneration.
His Visual acuity research is multidisciplinary, relying on both Tolerability, Adverse effect, Randomized controlled trial and Aflibercept. He interconnects Signal void, Melanin, Retina and Tomography in the investigation of issues within Retinal. The Optical coherence tomography study combines topics in areas such as Autofluorescence and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intravitreal aflibercept for diabetic macular edema.
Jean François Korobelnik;Diana V. Do;Ursula Schmidt-Erfurth;David S. Boyer.
Seven new loci associated with age-related macular degeneration
Lars G. Fritsche;Lars G. Fritsche;Wei Chen;Wei Chen;Matthew Schu;Brian L. Yaspan.
Nature Genetics (2013)
Fundus Autofluorescence and Development of Geographic Atrophy in Age-Related Macular Degeneration
Frank G. Holz;Caren Bellman;Stephanie Staudt;Florian Schütt.
Investigative Ophthalmology & Visual Science (2001)
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
Lars G. Fritsche;Wilmar Igl;Jessica N.Cooke Bailey;Felix Grassmann.
Nature Genetics (2016)
Fundus autofluorescence imaging: review and perspectives.
Steffen Schmitz-Valckenberg;Frank G. Holz;Alan C. Bird;Richard F. Spaide.
Retina-the Journal of Retinal and Vitreous Diseases (2008)
Progression of Geographic Atrophy and Impact of Fundus Autofluorescence Patterns in Age-related Macular Degeneration
Frank G. Holz;Almut Bindewald-Wittich;Monika Fleckenstein;Jens Dreyhaupt.
American Journal of Ophthalmology (2007)
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study.
Frank G. Holz;Winfried Amoaku;Juan Donate;Robyn H. Guymer.
RANIBIZUMAB FOR PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: SUBGROUP ANALYSIS OF FIRST-YEAR ANCHOR RESULTS
Peter K. Kaiser;David M. Brown;Kang Zhang;Henry L. Hudson.
American Journal of Ophthalmology (2007)
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M. Brown;Ursula Schmidt-Erfurth;Diana V. Do;Frank G. Holz.
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Frank G Holz;Ramin Tadayoni;Stephen Beatty;Alan Berger.
British Journal of Ophthalmology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: